Dr. Justin Bailey
Dr. Justin Bailey originally came from the province of British Columbia to pursue his undergraduate degree in Chemistry and Biology at the University of Alberta. In 2008, he moved on to pursue his Ph.D. in carbohydrate chemistry at the University of Alberta under the guidance of Prof. David R. Bundle. After completing his graduate studies, he served a short Industrial Postdoctoral Fellowship with the Alberta Glycomics Centre in collaboration with NovaDigm Therapeutics before accepting his current position as a Research Associate in Prof. Ralf Schirrmacher's laboratory in 2014. In 2018, Justin founded the university spin-off company Cerberus Radiopharmaceuticals with the focus of expanding and commercializing the intellectual property developed in Ralf's laboratory. His research interests include carbohydrate and medicinal chemistry, immunology, chemical biology, and of course, radiochemistry.